The ASPC 2021 Congress on CVD Prevention will be converted to 100% virtual this summer. The ASPC online scientific sessions will aim to bring attendees the same learning and connection they find at our face-to-face meeting. This year we will emphasize inclusiveness and the care of one and all at risk for cardiovascular disease. The program will provide cutting-edge lectures, lively debates, and practical applications. We will explore the broad spectrum of preventive cardiology led by world-renowned experts in the field. It will cover topics such as Emerging Therapies for Lipid Management, CAC vs. biomarkers, Chest pain guidelines and Imaging, Prevention of Heart Failure, Atrial Fibrillation, PAD evaluation, treatment, and management, practical application of New Prevention Therapies, CVD prevention in Special populations, and more.
This activity is designed for an audience of physicians, physician assistants, nurses, pharmacists, dieticians, research scientists and other healthcare professionals.
Upon completion of the educational activity, participants should be able to:
- Evaluate emerging lipid therapies and assess their ASCVD risk reduction while implementing this knowledge into clinical practice.
- Evaluate the literature involving CVD risk in CKD and DM patients in an effort to implement this knowledge into clinical practice.
- Compare the literature involving biomarkers versus CAC testing in ASCVD prevention and implement this knowledge into clinical practice.
- Assess and evaluate current ACS treatment strategies in patients with COVID-19 and implement into daily management.
- Review and assess chest guidelines and understand the diagnosis and management of patients presenting with chest pain utilizing new diagnostic clinical algorithms.
- Evaluate the latest literature to determine the pretest probability (PTP) of coronary artery disease (CAD) in symptomatic patients and how to proceed with test selection and implement this knowledge into clinical practice.
- Evaluate the literature involving diets to reduce cardiovascular risk and implement this knowledge into clinical practice.
- Evaluate the literature involving lifestyle modifications to prevent heart failure and implement this knowledge into clinical practice.
- Understand strategies to prevent atrial fibrillation and implement this knowledge into clinical practice.
- Evaluate the medical and lifestyle management of PAD that incorporate therapies to improve functional outcomes, reduce adverse cardiovascular, and limb events.
- Understand implementation strategies to improve care, prevent heart disease, and implement this knowledge into clinical practice.
- Evaluate best practices in telemedicine, including proper billing, and implement this knowledge into clinical practice.
Evaluate the literature involving transgender patients, CVD, and hormone replacement therapy and implementing this knowledge into clinical practice.
- Discuss current strategies to prevent heart disease, stroke, and diabetes through proper diet and accessibility and implement this knowledge into clinical practice.
- Evaluate the literature involving the unmet needs in the use of statins and aspirin in PLWHIV and review the incompleteness of the current guideline to implement any prevention knowledge into clinical practice.
- Evaluate the clinical data involving elevated cholesterol in patients less than 40 and implement prevention strategies into clinical practice.
Criteria for Success
Certificates of completion will be awarded based on the participant’s attendance and submission of the activity evaluation/claim credit form at http://akhinc.formstack.com/forms/20280. If you have questions about this activity, please contact AKH Inc. at firstname.lastname@example.org.
Credit provided by AKH Inc., Advancing Knowledge in Healthcare and The American Society for Preventive Cardiology.
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and The American Society for Preventive Cardiology. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 15.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of the CME activity, which includes participation in the evaluation component, enables the participant to earn up to 15.5 medical knowledge MOC points and 0 patient safety MOC credit in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
AAPA Credit Designation Statement
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 15.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Full notification of commercial support will be provided in the final course syllabus.
Submission Deadline: June 6, 2021
Abstract Submission Instructions
Accepted Abstracts will be Published in the American Journal of Preventive Cardiology.*
*Previously published abstracts are excluded.
Instructions for Submitting Abstracts
Abstracts for poster entries submitted for competition can only be accepted electronically and must adhere to the following guidelines:
- Abstracts are limited to 350 words. (Word count excludes the abstract title, author names, and affiliations.) Please include All authors names, credentials, and affiliations.
- Abstracts must be divided into sections: Title, Background, Methods, Results, and Conclusion that states the importance and potential implications of the observations.
- Abstracts must be proofread carefully to avoid errors before submission.
- Abstracts must contain generic drug names only.
- Abstracts must be submitted in clear English with accurate grammar and spelling of a quality suitable for publication.
- All authors must disclose all relevant financial relationships.
- Any funding support for the research must be disclosed.
- The main research findings should not have been presented at another major scientific meeting prior to presentation at the ASPC Sessions.
The purpose of the abstract is to define the precise subject of the presentation to an audience. Below you will find a checklist for abstract preparation. All abstracts are considered equally for selection, and the quality of the abstract is the single most important factor in the Committee's decision.
You will be asked for the following:
- Background - A concise description of your subject matter and prior work in this area.
- Methods - The experimental design or technique employed.
- Results - Outcomes & measurements, with statistical significance, if appropriate
- Conclusion - Conclusions, clinical pertinence, and value or for Workshops and Presentations, the prevailing point of view.
- Authors - For each author you must provide first and last name, city and state as well as preliminary financial disclosure information. If you would like to be considered for Early Career Research Award, the Primary/Presenting Author should also upload a brief paragraph describing their qualifications in the chosen subject area and/or a CV.
- Tables and Figures - Upload a table or figure that show results related to your research.
Abstract Submission Topics:
- ASCVD/CVD Risk Factors
- ASCVD/CVD Risk Assessment
- ASCVD /CVD Risk Reduction
- CVD Prevention – Primary and Secondary
- Preventive Cardiology Best Practices – clinic operations, team approaches, outcomes research
- Metabolic Syndrome
- Kidney Disease
- Novel Biomarkers
- Pharmacologic Therapy
- ASCD/CVD in Women
- ASCVD/CVD in Special Populations
- Heart Failure
- Ischemic Stroke
- Peripheral Artery Disease
- Alterative and Complimentary Approaches
If you do not see an appropriate topic listed above that best relates to your abstract, please contact the ASPC office at email@example.com or call 904-233-0282.
Acceptance and Presentation Process:
Abstract grading is blinded, and abstracts are pre-screened and selected by ASPC judges based on quality and merit. You will be notified no later than Friday, June 15, 2021. if your poster is accepted. All presenting poster authors are required to register for the 2021 Virtual Summit on Cardiovascular Disease Prevention July 23-25, 2021. Presenting Authors will receive a registration code for complimentary registration to the ASPC 2021 Virtual Summit on CVD Prevention.
You will receive further instructions for items needed in in the virtual abstract hall once your abstract has been accepted.
ASPC Early Career Awards
Early Career (in training students, residents, and fellows or members in practice for <5 years) will have the chance to compete for the ASPC's Early Career Research Award Cash prizes of $750, $500, and $250
New this Year! The top place winner will present on the agenda during the Early Career Abstract Session. The top 6 Early Career Abstracts will have a chance to compete LIVE for the second and third place Early Career Research Award during a rapid fire, with attendees of the Virtual Summit deciding the winners. Presenting Authors submitting for the Early Career Award must upload a CV with their submission.
If you are the first place recipient of the Early Career Research Award or chosen for the rapid-fire oral presentation session, you are required to register and attend the 2021 Virtual Summit on Cardiovascular Disease Prevention, as well as attend all abstract-related responsibilities.
All accepted abstracts will be displayed in the Virtual Abstract Poster Hall and have designated times for Author Q&A sessions.
The ASPC Abstract Committee will select the first place Early Career research winner to be present during the oral abstract session on Saturday, July 24, 2021.
Submit questions to firstname.lastname@example.org.
ASPC 2021 Virtual Summit Partnership Opportunities
Join us as a partner at the ASPC 2021 Virtual Summit on CVD Prevention: Protecting the Heart of One and All. The ASPC 2021 Virtual Summit on CVD Prevention program will emphasize inclusiveness and the care of one and all at risk for CVD, while providing cutting edge lectures and lively debates exploring the broad spectrum of preventive cardiology.
Building on the momentum from last year, we have some new and exciting ways for you to interact with your target audience of cardiologists, endocrinologists, primary care physicians, PhD researchers, and clinical team affiliates at the Summit including include nurses, nurse practitioners, physician assistants, pharmacists, and dietitians at the ASPC 2021 Virtual Summit.
Your partnership with the ASPC is greatly valued by our entire organization. Your participation adds to the overall experience of the Summit and is a critical part of our efforts to provide a cutting-edge educational experience for our attendees.
We are proud to offer an agenda led by distinguished faculty who are leaders in their fields, as well as an interactive partner showcase. On behalf of our Board of Directors and all the members we serve, we look forward to your participation.
Thank you for your consideration.
Peter Toth, MD PhD, FASPC
Why Become a Promotional Partner?
A unique opportunity to meet and network with attendees on a global scale!
- A 2.5 day interactive Virtual Summit with over 500 global ASPC attendees.
- Your company will appear on all supporter recognition materials, as well as listed on the summit web page, virtual platform, mention on social media outlets, and included in the ASPC mobile app.
- Each booth receives two complimentary 2021 Virtual Summit badges.
- Post Summit marketing recognition continues with OnDemand options for 90+ days.
- Offering various ways to engage with attendees through our 2021 Opportunities Guide.
We hope to see you at the ASPC 2021 Virtual Summit in July!
Questions regarding Sponsoring, Exhibiting, and Advertising Opportunities?
Contact Ashley France, Director of Events: email@example.com.
Please visit https://www.aspconline.org/2021virtualsummit/
This symposium will highlight and provide a meticulous overview of real-world evidence collected for optimizing outcomes in patients with type 2 diabetes, specifically aiming to reduce cardiovascular events, as well as patient hospitalizations, considering clinicians must know the best practices to keep their T2D patients healthy and out of the ER during these trying times.
After Completion of this educational activity, attendees will be able to:
- Examine current treatment guidelines for patients with T2D for effective management of cardiovascular risk
- Evaluate the real-world evidence for reducing CV events and hospitalizations to improve outcomes for patients with T2D
- Apply emerging clinical data on issues in management and prevention of CVD in patients with T2D
Peter P. Toth, MD, PhD, FCCP, FASPC, FAHA (Program Chair)
President, American Society for Preventive Cardiology
Director of Preventive Cardiology
Alison L. Bailey, MD, FASPC
Centennial Heart at Parkridge
Harold E. Bays, MD, FOMA, FTOS, FACC, FASPC
Medical Director and President
Louisville Metabolic and Atherosclerosis Research Center
Pam R. Taub, MD, FACC, FASPC
Director of Step Family Foundation Cardiovascular Rehabilitation and Wellness Center
Associate Professor of Medicine
La Jolla, CA
Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This Continuing Education Activity is sponsored by unrestricted educational grants for Boehringer Ingelheim Pharmaceuticals and Lilly USA, LLC.
Host a CME or Non-CME Satellite Symposium at the ASPC 2021 Virtual Summit.
Satellite symposia can be Non-CME or CME sessions that address educational needs and performance gaps that complement the ASPC Congress scientific program agenda. The following guidelines provide important information regarding holding a Satellite Symposium at the 2021 Virtual Summit.
Questions regarding Satellite Symposia?
Contact Maggie Kincaid: firstname.lastname@example.org
Welcome to the ASPC 2021 Virtual Fun Run!
7.2 miles in 2 weeks, you’ve got this! Exercise anywhere you want, choose any cardiovascular activity, and then log the activity to see yourself move on our map and leaderboards. There are over 50 activities that can be converted to miles!
Our virtual race location is currently set to the beautiful streets of Paris!
If you are interested in SPONSORING the ASPC 2021 Virtual Fun Run, let us know and you can help us make the final location selection!
Racers can register from all over the globe! Here are a few more details:
- Race begins on July 6th and concludes July 20th.
- We rely on the honor system... you don't have to use a device to prove your miles, just log your activity and we’ll track your progress.
- Please attribute your activity to the appropriate day -- don't combine workouts from multiple days.
- Activities submitted after the race ends will not count toward race leaderboards.
We welcome photos! Please submit your Fun Run photos to: ASPCvirtual21@asponline.org and you just might see your photo during the Virtual Summit!
Questions regarding the ASPC 2021 Virtual Fun Run?
Contact Christine Canevari, Education Manager: email@example.com.